Defibrillator Market: Market Size & Forecast 2026

Defibrillators are life-saving medical devices that deliver an electric shock to restore a normal heartbeat during cardiac arrhythmias such as ventricular fibrillation. The market spans three primary device categories, AEDs, implantable cardioverter defibrillators, and wearable cardioverter defibrillators, each serving distinct patient populations and care environments. Rising incidence of sudden cardiac arrest globally, combined with growing awareness of the importance of rapid defibrillation, underpins sustained market expansion.

• •Global market valued at approximately $13.16 billion in 2025
• •Expected to reach roughly $16-19 billion by 2030-2035 depending on source methodology
• •Growth driven by aging populations and rising cardiac disease burden worldwide

The global rise in cardiovascular diseases, including coronary artery disease and heart failure, remains the most significant driver of defibrillator demand. Government regulations mandating AED placement in public spaces, such as airports, schools, and sports facilities, have substantially broadened the addressable market for automated devices. Additionally, technological improvements in miniaturization, battery longevity, and integration with electronic health records are accelerating replacement cycles and new installations in both clinical and non-clinical settings.

• •Increasing prevalence of cardiovascular disorders and sudden cardiac arrest incidents
• •Public access defibrillation programs and legislative mandates for AED deployment in public areas
• •Ongoing product innovations in device size, ease of use, and data connectivity

By product, implantable cardioverter defibrillators represent the largest revenue segment, driven by an aging patient population requiring cardiac rhythm management. AEDs are the fastest-growing segment due to expanding public access initiatives. Geographically, North America currently holds the largest market share due to advanced healthcare infrastructure, high disease awareness, and strong regulatory support, while the Asia-Pacific region is anticipated to post the fastest growth as healthcare access expands in emerging economies.

• •North America leads the market, supported by established healthcare systems and widespread AED adoption
• •Europe and Asia-Pacific represent significant and growing regional markets
• •Asia-Pacific is projected to be the fastest-growing region due to rising healthcare investment and cardiac disease awareness

What are the recent trends and outlook?

The integration of artificial intelligence for arrhythmia detection and treatment recommendations is emerging as a key differentiator in next-generation defibrillator devices. The shift toward home healthcare and remote patient monitoring is creating new demand for wearable and telehealth-enabled defibrillation solutions. Over the medium term, the market is expected to continue expanding steadily, supported by aging demographics, improved resuscitation guidelines, and increasing adoption of public access programs worldwide.

• •Artificial intelligence and machine learning are enhancing arrhythmia detection accuracy and device decision-making
• •Wearable cardioverter defibrillators and home-use devices are gaining traction as care shifts outside hospitals
• •Market projected to sustain steady expansion through the early 2030s as awareness and access programs proliferate